Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Superbugs & Superdrugs - A Focus on Antibacterials

5th March to 6th March 2014, London, United Kingdom

Overview

Open/Close

The growing threat of bacterial resistance has been underscored by governments, medical personnel and academia alike. These threats have been compared to that of terrorism by the Chief Medical Officer of the UK. Following from last year's very successful event, SMi is proud to present its 16th Annual Conference on Superbugs and Superdrugs.

This event is a well established one and is very famous in its niche market. This year’s focus will be on how to address this ever increasing bacterial resistance. The conference will also address the main challenges that pharmaceutical companies are currently facing in terms of funding and low unit price of antibiotics and will look at how these companies can go into partnerships and have access to funds and wider expertise

This exciting event will bring together industry leaders from big pharma companies, biotech companies, regulatory agencies and academia to discuss the latest development in the antibacterial market. This unique conference will present attendees with a complete view into the latest research in combating multi-drug resistance.

Key areas to be discussed in this year’s conference are:

• Research and development in neglected diseases
• Horizons for antimicrobial resistance (AMR)
• Controlling the use of new antibiotics
• Public/private partnerships and how you can benefit from it
• The latest treatment for Hepatitis C
• Antibody based strategies
• Nanoparticles approach to treat Gram-Positive and Gram-Negative pathogens
• Regulatory aspects of for new antimicrobials
• Alternative models for tackling antimicrobial resistance

The conference will be made up of a number of presentations and case studies from key opinion leaders and updates on their latest research projects and real life success stories for all attendees to learn from.

March 2013 testimonials include:

"Very well organised conference" - GSK
"Good level of quality" - Janssen
"Very good and engaging speakers" - Merck
"Good topics, mix of basic research and clinical development and perspectives" - J&J

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close